Background: Knowledge, perceptions and prescribing behaviour are key to antibiotic prescribing. The aim of this paper is to systematically review this. Method: An extensive literature search from 1990-2014. Results: 19 articles were included; 8 in ambulatory care, 7 in hospital settings, and 4 in both, across all countries. Physicians still have inadequate knowledge and misconceptions about antibiotic prescribing. Moreover, some physicians although aware that antibiotics are of limited benefit in some conditions still prescribed them. Several factors influenced prescribing including patients' expectations, severity and duration of infections, uncertainty over diagnosis, potentially losing patients, and influence of pharmaceutical companies. Pocket-sized guidelines seen as an important source of information for physicians. Conclusion: Inadequate knowledge of prescribing is prevalent among physicians. However, many physicians were interested in improving their antibiotic prescribing. Multifaceted interventions targeting all key stakeholders including patients are needed to improve future antibiotic prescribing.
Introduction
Infectious diseases were the leading cause of morbidity and mortality before the discovery of antibiotics. This changed with their advent through researchers including Paul Ehrlich and Alexander Fleming, turning once fatal diseases into more manageable health problems (1) (2) (3) (4) . Advances in scientific and medical technology has resulted in the development of new antibiotics as well as generic antibiotics, with the latter in particular providing easy accessibility at affordable costs (5) . Antibiotics are now commonly prescribed to patients in ambulatory care (6) (7) (8) (9) . However, greater accessibility has resulted in irrational and excessive use, leading to increasing antibiotic resistance (5, (10) (11) (12) (13) (14) . Increasing antimicrobial resistance is seen as one of the most critical problems facing healthcare systems (15) , with estimates that antimicrobial resistance (AMR) infections currently cause approximately 50,000 deaths a year in Europe and the US alone (1) . This increases to several hundred thousand deaths each year when other countries are included (1) . The continual rise in AMR is envisaged to result in 10 million deaths annually by 2050 unless checked. As a consequence, AMR infections could be a leading cause of death by 2050. This death rate will reduce GDP by 2% to 3.5% by 2050 and costing the world up to US$100trillion (1) . Some common infections, especially those (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement and guidelines were followed when performing the search and the identification of possible studies (43) .
Relevant studies were identified by a comprehensive search of several electronic databases. These included Scopus, PubMed, ISI Web of Knowledge, Proquest, Science Direct online library and Google Scholar. The bibliography of the retrieved studies was also checked for potential studies. The search strategy involved using Boolean operators for combinations of several keywords to identify the relevant articles. The key words used in the search included (antibiotic(s) OR antimicrobials) AND (prescribing OR resistance) AND (knowledge OR practice) AND (attitude OR perception). For prescribers, the following keywords were used: prescriber(s), general practitioner(s), doctor(s) and physician(s). Articles related to antibiotic use in dental practices were excluded from the systematic review. We acknowledge that particularly in LMIC countries the prescribing and dispensing may be undertaken by non-physicians, e.g. pharmacists, even when this is not permitted (21, 44) . However, these papers have been excluded from the review as our focus was on physicians.
To make the review relevant to current practice, the search was restricted to the studies published between 1990 and 2014. Only articles published in the English language were included. All results were listed and evaluated by reading the abstracts. To determine whether the studies met the required criteria, the lists of titles and abstracts from the searches were examined by two researchers independently. Where doubt remained, the full article was examined by two of the researchers to determine whether it is relevant, with the final inclusion of the article undertaken in a consensus meeting involving the authors.
The methodology, including summarizing the quality and limitations of studies, follows previously published studies (45) (46) (47) .
Results
The search process resulted in 1633 titles and abstracts. After removing duplicates, 1052 studies were screened, of which 764 were excluded on the basis of title. Further assessment of title and abstracts led to the identification of 145 studies not meeting eligibility criteria, as they were not related to the topic and did not investigate perceptions, attitude or knowledge of the prescribers towards antibiotics. The remaining (n= 143) were full-text assessed for eligibility for inclusion in the study. Seventy eight studies were then excluded as their main findings did not discuss issues related to our review objectives. A further 46 studies were excluded as they did not assess physicians' perceptions and knowledge, but rather looking at the prescribing patterns and variability in antibiotic usage. This left 19 articles for inclusion in the review (Table 1) .
Insert Table 1 .
The PRISMA diagram for this review is shown in Figure 1 . 
Methodological quality
Each study was reviewed and a consensus meeting was convened to ensure quality assurance. The most prominent pitfall identified was a lack of generalizability of the study results to whole populations, as most studies were restricted to certain geographical areas, countries, or provinces/ regions. There were two studies in which limitations were not mentioned by the authors (48, 49) . In addition, three of the studies had a response rate less than 50% (29, 50, 51) , which can be a limitation to the generalization of the results of these studies. In some of the studies, participants were from different specialties and treating different infectious diseases (51) (52) (53) (54) , while other studies were specific and a certain disease condition such as paediatric common colds (49) , URTIs (29, 35, 50, 55, 56) , and surgical site infections (57) . In some of the studies, the authors stated that the respondents may be triggered to the topic and gave socially desirable answers [23] . Four of the included studies (56, (58) (59) (60) incorporated qualitative methodology and although they addressed the topic with an in-depth exploration, their findings are not possible to be generalized.
 Characteristics of selected studies
The study setting was ambulatory care in eight studies (29, 35, 48, 49, 56, (60) (61) (62) , hospital setting in seven studies (51, 52, 54, 57, 63, 64) and both primary and hospital care in four studies (39, 50, 55, 58) . Sixteen studies focused solely on physicians, while three studies included pharmacists, patients or the general public. However, for the studies that also reported results related to other groups, e.g. pharmacists and/or patients, only their results related to physicians are reported in this review.
In these studies, the response rates varied widely from 33% to 87% (Table 1 ). The lowest response rate (33%) was reported in a Spanish study. By using telephone call reminder and follow up, Wester et al and Mohan et al achieved higher response rates, 87% and 84.4% respectively (35, 53) .
With respect to the disease/clinical condition, ambulatory care infections including URTIs, diarrhoea, the common cold and sore throats were the subject of 11 studies (29, 35, 39, 48-50, 55, 56, 58, 60, 61, 64) . Other studies targeted infections in various specialties in hospital settings. As shown in Table  1 , it is important to note that the study variables and objectives varied between the different studies. Some of them focused on knowledge and other studies focused on attitudes or beliefs or prescribing practices.
Main findings
The findings will be divided into five sections starting with the knowledge of physicians regarding the prescribing of antibiotics
 Knowledge of physicians regarding the prescribing of antibiotics
Six studies evaluated the knowledge of physicians towards antibiotic use and resistance (39, 51, 53, 54, 64, 65) .
Three studies, from the United States (US), UK and Peru, assessed doctor's knowledge regarding antibiotic use in upper respiratory tract infections (URTIs) (29, 61, 64) . In the US study, 99.5% of the surveyed residents thought they had at least average knowledge about the treatment of URTIs (29) . Most participants agreed that there was no need to start antibiotics in mild cases of URTIs in the US (81%) and Peru (76%), but a considerable percentage thought that more symptomatic events, such as patients with purulent nasal discharge, would need an antibiotic (29, 64) . Physicians in UK acknowledged that antibiotics were prescribed too often for URTIs in primary care settings, although they were aware of the evidence for the limited effect of antibiotic treatment in this situation (61) . Moreover in these studies, physicians commented on reducing antibiotic usage in URTIs and the relationship with the treatment outcome (49, 61, 64) .
Cho et al in Korea conducted a study on the prescribing of antibiotics in children with a common cold. The study showed that physicians in this study agreed that they could reduce by more than a quarter their antibiotic use without jeopardizing their patients' treatment outcome. Nevertheless, 72.8% of physicians believed antibiotics could reduce the occurrence of complications. In other studies, physicians in United Kingdom (61) and Peru (64) thought that prescribing narrow spectrum antibiotics, and prescribing them occasionally, could do little or no harm in terms of the development of antibiotic resistance. Chamany et al (50) in the US found that majority of the physicians (92%) agreed that fewer antibiotics will reduce the risk of antibiotic resistance. However they were concerned about patients' dissatisfaction if antibiotics were not prescribed. Consequently, 64% of them thought it was necessary, and would eventually prescribe antibiotics to their patients with upper respiratory tract infections. Similar results were reported by physicians in Europe where they felt that antibiotic prescribing should be minimized to prevent escalating of antibiotic resistance (56).
 Attitudes and confidence level in making antibiotic decisions
Five studies assessed confidence levels among the physicians in their prescribing of antibiotics.
There was a strong consistency among physicians with respect to their confidence level in making decisions on antibiotic prescribing. Some doctors especially junior doctors or those in their internship always discussed URTI care with senior physicians (59%-98%), yet only 2.8% to 5.4% of them did not feel confident making decisions regarding treatment (29, 39, 65) . Some of the physicians in Peru and DR Congo (31% and 54.5% respectively) agreed it is difficult to select the correct antibiotics for their patients (39, 64) . However in one study by Srinivasan et al, those who reported they were very confident in their antimicrobial use did not appear to have a better knowledge regarding antibiotics than those who were not confident (54) . Despite their confidence, physicians find it difficult to select correct antibiotics for their patients. As a result, physicians do consult a colleague when prescribing antibiotics (39) . However, this is less likely in the private sector where physicians prescribe in isolation 82% of respondents in a US study opted to use a diagnostic test (rapid antigen detection test or culture) to help decision making in the management of URTIs (29) . However in two studies conducted in LMICs (35, 52) , doctors did not favour using laboratory services due to a lack of, or limited, diagnostic facilities coupled with a delay in receiving the test results; alternatively, the belief that it is not necessary. In addition, in countries where payments for healthcare services are by the patient, i.e. out-of-pocket payments, physicians did not want to burden their patients with laboratory fees where they could not afford these (60) .
 Awareness towards antibiotic resistance
Most of the studies reported that physicians had a general idea about the problem of resistance and its consequences. However, the majority of the studies reported that physicians had a low level of knowledge regarding the prevalence of antibiotic resistance rates in their local settings (39, 51, 53, 64, 65) . For example, Pulcini et al. showed that only 16% of young doctors in a French hospital knew the actual proportion of community acquired-Escherichia coli resistant to fluoroquinolones (65) . Similarly, only 10% respondents in DR Congo knew about Klebsiella spp. resistant to ceftriaxone (39) . However, physicians who specialized in infectious disease (ID) estimated antibiotic resistance rate more accurately compared to physicians in general medicine and other non-ID subspecialists (53) . In two of the studies, senior residents in Spain and junior doctors in United Kingdom knew more about the prevalence of MRSA compared to other physicians in their practicing centres (51, 65) . In these studies, years of practice and past training experience did not influence physicians' knowledge level.
Physicians from three studies (48, 49, 61) agreed that antibiotic overuse in outpatients contributed to the emergence of resistance. Contrary to this, participants from three studies considered antibiotic use in secondary healthcare or hospital setting as the main contributor to the existence of resistance (56, 58, 59) . Encouragingly, over 90% of physicians in two studies in the US agreed that there would be a reduced risk of antibiotic resistance infections if fewer and better use of antibiotics were practiced (50, 54) .
 Source of information and familiarity with guidelines
Several studies evaluated the main sources of information used by physicians regarding antibiotics. The majority of the physicians in the studies were familiar with guidelines related to antibiotics, but still some were not using them. For example in Sudan, only 32.6% of physicians referred to Sudan National Formulary (SNF)or the British National Formulary (BNF), while the remainder did not use any reference source for their decision making (57) . Physicians in Peru referred to the Sanford Guide on Antimicrobial Therapy for information regarding antibiotics, and considered it as a very useful source (64) . Similarly, 66.3% of physicians in DR Congo referred to guidelines when making treatment choices. However, the WHO Guidelines appeared to be the least popular as an information source as only 26.6% of them stated they used them as a reference (39) . Physicians in Spain appreciated the recommendations contained in clinical guidelines; however, preferred these to be adapted to the local situation (59).
Pocket-based antibiotic guidelines were rated as the most useful source of information. For example, the majority (98%) of the respondents in a US study and 50% in two public hospitals in Peru used 'The Sanford Guide', a pocket-sized guideline (39, 54) . Physicians in India wanted antibiotic guidelines to be provided in all community hospitals to assist them in their appropriate use (60) . However, 36% of respondents in Peruvian hospitals said the national guideline was not useful, while 25% said they were not familiar with it (64).
In several studies, pharmaceutical companies were regarded as one of the major influences of antibiotic prescribing. For example, 20% of the physicians in US reported that their interaction with pharmaceutical representatives influenced their own antimicrobial selections (54) . Similar result were found in a Spanish study by Vazque-Lago et al where physicians attributed a very clear influence from pharmaceutical promotion and advertising when it came to choosing antibiotics (59) . However in Trinidad, general practitioners did not feel pressured by pharmaceutical companies promotional efforts to prescribe antibiotics to their patients (35) . Other than clinical guidelines and information provided by the pharmaceutical companies, physicians also believed in educational courses and internet-based information to assist with future prescribing of antibiotics (39, 64) .
 Practice and factors influencing prescribing behaviour
Several factors were reported in the literature that could influence prescribing behaviour. 73% of physicians in Korea reported that parents expected an antibiotic prescription during the consultation. Consequently, 40% of them prescribed antibiotics even if they felt these were unnecessary (49) . Similar results have been found in DR Congo where 62% of physicians perceived patients pressure being a contributing factor to the overuse of antibiotics in the community (39) . However in South Africa, the prescribers reported that they were least influenced by patients' request or expectations (52).
Among other reported reasons for prescribing antibiotics were the severity of illness and duration of infections (35) , to avoid secondary bacterial infections (35, 55) , or because of uncertainty between bacterial or viral infections (55) , following patients' request or perceived request (49, 50, 60, 61, 66) , and afraid of losing patients (49, 60) . More than half of European primary care paediatricians (65.1%) reported of using delayed antibiotic prescribing in management of URTIs, a method which is recommended by the National Institute for Health and Clinical Excellence (NICE) (55) .
Other factors influencing the prescribing of antibiotics, including economic factors as well as the availability and supply of antibiotics, were not typically mentioned in the papers incorporated into this review. However, it is acknowledged they do influence prescribing (19, 21, 25) .
Discussion
The same sections will be discussed to provide future guidance
 Knowledge among physicians regarding antibiotics and antibiotic resistance
This systematic review showed that physicians had a general idea about antibiotic resistance as a clinical problem, but they were underestimating its prevalence. Knowledge of antibiotic resistance rates was not related to the level of experience among the practitioners. In this aspect, physicians have an overview of resistance as a problem, showing a high level of awareness that this may jeopardize future patient care. However, few perceived that antibiotic resistance was an important problem in their own clinical practice, suggesting that many physicians see the risk of antibiotic resistance as more theoretical than actual, possibly weakening the motivation for behaviour change (53) . Although many doctors agreed that reducing antibiotics will reduce the risk of antibiotic resistance, there is still there a high proportion reporting they would prescribe antibiotics for conditions for which antibiotics are not usually indicated. This indicates that several external factors may also influence their prescribing. Identified factors included avoiding patients' dissatisfaction, and sometimes their own belief that the antibiotic would be necessary (50) . Also, they may believe that they are more effective as physicians when they prescribe medications to treat their patients, even though this may be unnecessary. However, this is speculation at this stage and needs further research. In any event, this underscores the importance of educational sessions including active drugs and therapeutic committees (DTCs) and dissemination of guidelines as well as the availability of local resistance data to improve future antibiotic prescribing (20, 24, 25, 51, 67) .
Regarding their practice, physicians believed that wide and easy access to up-to-date information would allow them to make more informed decisions about antibiotic prescribing, including selecting narrow-spectrum antibiotics that are most likely to be effective (56) . However, the low average score of knowledge regarding antibiotic use and resistance suggests that antimicrobial education has been suboptimal (54) . Reduced knowledge has made physicians, as well as the patients, believe that antibiotics are standard treatment for a number of conditions even if this may not be the case. It is also believed that physician personal experience with antibiotic resistance will increase their awareness about the importance of harmful effects caused by antibiotic resistance (53) . Knowledge and appropriate antibiotic use may also improve as physicians advance through education, training and clinical practice. Consequently, improving antibiotic prescribing through training physicians in continuing medical education programmes, and issuing clinical guidelines for their appropriate use based on local microbiological data, are important strategies(60).
The review by Huttner et al showed that a number of interventions can be used to educate physicians regarding the prescribing of antibiotics. These include academic detailing, audit and feedback of prescribing behaviour as well as the distribution of guidelines (68, 69) . Other authors have shown that the implementation of guidelines and subsequent improvement in prescribing is enhanced by keeping them up-to-date, involving all key stakeholders in their compilation, as well as incorporating multiple components in their implementation (26, 70) . This includes active dissemination strategies coupled with monitoring and feedback of prescribing patterns as well as keeping guidelines simple and limited in number (69) (70) (71) (72) (73) (74) (75) (76) (77) . Trust in those developing the guidance is also important given the appreciable potential for bias (72, 73, 78) . Multiple interventions can be divided into managerial approaches alongside educational interventions (20) . Managerial interventions include computerized decision support systems, prescribing indicators, community case management programmes, formulary restrictions and prior authorisations (19, 20, 25, 79) . The added influence of multiple interventions alongside educational activities to favourably influence physician prescribing has also been shown in other disease areas with interventions including indicators, financial incentives to all key stakeholder groups and prescribing restrictions (80) (81) (82) (83) . Barriers to change not only relate to physicians but other parties including patients, health care systems, available resources, leadership and the current political environment. Consequently, strategies need to be tailored and targeted at different levels to improve the future use of medicines including antibiotics (70).
 Attitudes and confidence level in making antibiotic decisions
Many studies in the literature reported that junior physicians or physicians in training were less confident about antibiotic prescribing compared to attending physicians with more years of clinical experience. Low knowledge of antibiotics may account for less confidence among the physicians in their ability to use antibiotics optimally (54) . Physicians without a recent formal teaching or training on antimicrobials were less knowledgeable compared to those with exposure to formal teaching, suggesting that when education does occur it is effective (54).
Furthermore, physicians in the first year of practice chose antibiotics more frequently for viral URTIs than did those in longer period of practice (29) . This suggests it is important that the rational use of antibiotics and antibiotic resistance are adequately covered and emphasized during medical education. Junior doctors should also be a target group for future interventions to improve antibiotic prescribing.
 Practice and factors influencing prescribing behaviour
Patient demand and perceived need for a quick relief of their symptoms does appear to promote inappropriate antibiotic use. Attempting though to change patient's beliefs and expectations during the consultation is often perceived as time-consuming and unrewarding (61) . Physicians, especially those at outpatient settings, do respond to the demands of patients by prescribing antibiotics rather than providing explanations why antibiotics are not needed. This though can raise concerns that some physicians practice 'throwing antibiotics at everything', taking the easy way out rather than spending some time discussing potential treatments including why not prescribing antibiotics with their patients (50) . However, in today's healthcare system where physicians in many countries have only a few minutes to fully evaluate the patient, make a diagnosis and prescribe a treatment, and given the increasingly litigious nature of society, they frequently find themselves under tremendous pressure to prescribe an antibiotic even when this may not be appropriate (4).
These findings highlight the need for training for physicians to educate patients in the rational use of antibiotics, especially in outpatient settings, in order to improve their practice. Educational interventions and campaigns to improve antibiotic prescribing must also target patients as they do influence prescribing decision. Patient campaigns could include education by healthcare professionals, distribution of leaflets and posters in public places, e.g. shopping malls, bus stations, and clinics as well as mass media including newspaper advertisements and possibly the TV, building on examples in the literature that have resulted in a more judicial use of antibiotics (68) .
A number of campaigns have been successfully undertaken across countries to improve antibiotic use. This includes Australia, Chile, Europe and Korea. A summary of the programmes and their impact are contained in Table 2 . (20)  The National Prescribing Service (NPS) conducted an antibiotic promotion programme to promote the quality use of antibiotics  The programme targeted general practitioners (GPs), pharmacists and consumers, with activities including academic retailing or clinical audits, prescribing feedback (for GPs), newsletters and promotional materials to consumers via radio, TV, and local newsletters. In addition, books and resources were distributed to GPs and community pharmacies  The programme has resulted in a major reduction in antibiotic use, e.g. In line with implementing suggested prescribing approaches, communication skills and certainty of the diagnosis ranked among the highest indirect factors influencing antibiotic prescription (90) . Physicians may feel that using prescriptions to bring a difficult consultation to a conclusion was the only way to get through a busy clinical schedule (91) . This factor is also related to patients' expectations, where some studies showed that improvement in communication between physician and patients can reduce patients' expectation to antibiotic treatment (92) (93) (94) .
In (95) . This has been conducted under the annual National Medicines Use Survey. Future activities include ascertaining point prevalence data where patient level data will be collected and fed back to physicians to improve future antibiotic prescribing as well as campaigns with patients.
 Source of information and familiarity with guidelines
In the various studies, there were several information sources available to physicians. These include colleagues, pharmaceutical company representatives, guidelines, electronic data sources, and medical journals. Pharmaceutical companies appear to exert appreciable influence on antibiotic usage. This was demonstrated by Sondergaard et al, who showed that visits from pharmaceutical representatives had a significant impact of physicians' subsequent prescribing (96) . Similar result has been reported in by McGettigan et al, who found that information on new medicines prescribed had come from pharmaceutical representatives in 42% of cases (97) . This is not surprising, as pharmaceutical companies engage in an appreciable number of activities to enhance the funding and utilisation of their medicines (98) (99) (100) (101) . However, some physicians reported that they prescribed promoted medicines within a certain time period and when the promotion from pharmaceutical companies stopped, physicians claimed they would also stop prescribing the medicines (59).
Typically, information provided by pharmaceutical companies ranked among highest choice of references among physicians. This highlights the prominent role of pharmaceutical industry as a key source of information about medicines, especially in low and middle income countries (17, 102, 103) . This is of concern as drug promotion, especially in developing countries, may not always be evidencebased adversely impacting on future care (17, 104, 105) . Undue pressure on healthcare providers by pharmaceutical companies may also increase inappropriate use (43, 76) . Consequently, it is important to counteract this influence if this adversely affects the rational use of medicines. Several countries have taken steps in this regard (83, (106) (107) (108) . In Croatia, pharmaceutical companies are required to report all their promotional expenses as well as financial remuneration to physicians for prescribing. Contact between pharmaceutical company representatives and physicians is also limited, enforced through financial penalties (83) . In South Korea, by law pharmaceutical companies must not pay for physicians to participate in conferences, leading to fines for abuse (106) . In the US, pharmaceutical companies are now required to report their gifts and payments to physicians (108) . These countries provide examples on how relationships between pharmaceutical companies and healthcare professionals can be addressed to reduce their influence on future prescribing, reducing potential concerns (109).
Pocket-sized treatment guidelines seem to be most popular as an information source, suggesting that small and handy types of references are more preferred and more accessible. This is important as poor adherence to guidelines increases medication risks and decreases antibiotic benefit through wrong choices and dosing by physicians (58).
We are aware that eleven of the included studies were conducted in developed countries (29, 49-51, 53-56, 59, 63, 110) , while eight studies were conducted in developing countries including Bangladesh, DR Congo, India, Lesotho, Peru, Sudan and Trinidad and Tobago (35, 39, 48, 52, 57, 58, 60, 64) . There are appreciable differences in healthcare delivery between developed and LMICs, with limited information and lack of resources creating barriers to accessing and providing adequate healthcare in developing countries. This does create differences. Having said this, physician knowledge of resistance appeared adequate across studied countries with most studies reporting that physicians had a general idea about the problem of resistance and its consequences. However, this did not always translate into appropriate prescribing of antibiotics. This may be due to patient pressure to prescribe antibiotics among both developed and developing (LMIC) countries. Differences between countries included the fact that in developed countries, internet based information served as a common resource of information. This is in contrast with the developing (LMIC) countries where internet resources are used by only some physicians. Limited access to internet connection and other electronic facilities has made information from the internet more difficult to access compared to other available resources (39) . This though is likely to change in the future. Knowledge and perceptions among physicians in LMICs may also be different. They agree that antibiotic prescriptions can be reduced; however, they believed that prescribing narrow spectrum of antibiotics occasionally are safe (64) . Choosing correct antibiotics are often difficult in LMICs due to a lack of local guidelines and limited access to up-to-date international guidelines; therefore the majority of physicians will consult a colleague when doing so (39, 64) . Physicians in LMIC also believe laboratory tests may not always be necessary, due in part to limited of diagnostic facilities, delay in receiving the test results, and many patients unable to afford laboratory fees (60) . Physicians in LMIC countries may also feel pressured by pharmaceutical company promotions; however, this is not universal (21, 35, 98) . Other factors influencing antibiotic utilization in LMIC countries relate to the health system, i.e. unavailability of the recommended antibiotic (24), oversupply of antibiotics and near-expiry antibiotics in some primary healthcare centers (21), as well as economic benefits from prescribing certain antibiotics over others (21, 24, 33) .
We are also aware that we included different physician specialties. This is because of the very limited number of studies that only concentrate on one physician group. For example, Fakih et al included residents from different specialties, i.e. internal medicine, family medicine, emergency medicine and paediatrics (29), Grossman et al and Cho et al included primary care/ family physicians and paediatricians (49, 55), Pulcini et al included physicians from different medical and surgical specialties (63) , and Srinisavan et al studied physicians from different medical specialties including general medicine, emergency medicine, Obstetrics/ gynaecology, surgery and neurology (54) .
Other limitations include the fact that the literature search was carried out based on electronic databases to which the authors' university library subscribed. As a result, it is possible that some studies might not have been retrieved. In addition, papers that were published in languages other than English were excluded from the review. Moreover, the review focused on the recent literature, i.e., from 1990 and onwards. However, we believe this is justified because older studies might not be relevant to current practices. Nevertheless, overall we believe the findings of this systematic review are robust and can provide excellent guidance for the future to promote the rational use of antibiotics.
Conclusion
It is evident from the various studies that inappropriate prescribing and knowledge of antibiotics is a concern among physicians in general and young physicians in particular, with physicians willing to prescribe antibiotics even for viral illnesses. Several factors appear to influence prescribing behavior. These include demands from patients, pharmaceutical company marketing activities, limited up-todate information sources and physicians afraid of losing their patients. Inappropriate prescribing of antibiotics when it occurs also appears to be related to inadequate knowledge or training on the appropriate prescribing of antibiotics. It was encouraging to see that physicians were interested in learning more and improving their prescribing practice to address this. The majority of the physicians in the studies also wanted more feedback on their antibiotic prescribing decisions. Issues of supply, healthcare infrastructure as well as financial incentives can also affect subsequent antibiotic prescribing and utilization especially in LMIC countries.
This provides guidance for the future given the projected mortality and financial implications if the increase in inappropriate antibiotic prescribing and AMR is unchecked. Typically, multifaceted and multilevel interventions strategies that target all key stakeholders, including physicians and patients, are needed to improve the rational use of antibiotics thereby helping reduce resistance development.
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Key points
 Understanding physicians' knowledge regarding antibiotics, how this knowledge is acquired and maintained, as well as factors influencing the prescribing of antibiotics is key to introducing future strategies to enhance the rational use of antibiotics. As a result, help reduce future resistance development  A systematic review was undertaken to assess current knowledge to provide future direction. This eventually involved 19 papers from 1633 titles and abstracts once only pertinent papers were included. The studies were across healthcare sectors and involved both developed and developing countries  The main findings showed that some physicians still have inadequate knowledge and misconceptions about antibiotic prescribing. In addition, whilst aware that antibiotics are of limited benefit or unnecessary for some conditions they were still prescribed  Influencers of physician prescribing included patients' requests and expectations, severity and duration of infections, belief that antibiotics can prevent secondary bacterial infections, uncertainty between bacterial or viral infections, potential losing of patients if antibiotics are not prescribed, influence of pharmaceutical companies and limited access to information sources on antibiotic prescribing  Pocket-size guidelines were seen as the most important source of information on antibiotic prescribing. This along with future training and feedback will help improve future antibiotic prescribing  Educating patients is also important to improve the future rational use of antibiotics 
